EnBioTec And Tripos Discovery Research Centre Have Entered Into An Agreement To Develop Nuclear Receptor Based Lead Chemicals

November 7, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo, Japan - EnBioTec Laboratories Co., Ltd. based in Tokyo Japan has entered into an agreement with Tripos Discovery Research to co-develop nuclear receptor based lead compounds for drug discovery.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia